Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy
Epilepsia ( IF 6.6 ) Pub Date : 2021-08-29 , DOI: 10.1111/epi.17049 Brett E Youngerman 1 , Uma V Mahajan 2 , Timothy G Dyster 3 , Shraddha Srinivasan 4 , Casey H Halpern 5 , Guy M McKhann 1 , Sameer A Sheth 6
Epilepsia ( IF 6.6 ) Pub Date : 2021-08-29 , DOI: 10.1111/epi.17049 Brett E Youngerman 1 , Uma V Mahajan 2 , Timothy G Dyster 3 , Shraddha Srinivasan 4 , Casey H Halpern 5 , Guy M McKhann 1 , Sameer A Sheth 6
Affiliation
We evaluated the incremental cost-effectiveness of responsive neurostimulation (RNS) therapy for management of medically refractory focal onset seizures compared to pharmacotherapy alone.
中文翻译：
反应性神经刺激治疗耐药局灶性癫痫的成本效益分析
我们评估了反应性神经刺激 (RNS) 治疗与单独药物治疗相比治疗药物难治性局灶性癫痫发作的增量成本效益。
更新日期：2021-11-02
中文翻译：
反应性神经刺激治疗耐药局灶性癫痫的成本效益分析
我们评估了反应性神经刺激 (RNS) 治疗与单独药物治疗相比治疗药物难治性局灶性癫痫发作的增量成本效益。
京公网安备 11010802027423号